Fewer patients achieved the PASS threshold than the MCII threshold.
A total of 82.8% of the participants achieved a pass mark of 80% or above; 42.8% of participants achieved the pass mark at 6 months, 41.7% at 9 months and 11.7% at 4 years (compared with pre-test, P < 0.001).
Only 39 participants prior to commencement of the course achieved the pass mark compared to an 82.8% pass rate immediately after the training.
At stage 3, 42.8% of participants achieved the pass mark of 80%; 41.7% passed at stage 4 and 11.7% at stage 5 (higher compared with pre-test, p < 0.001).
Figure 1 illustrates the scores at the five stages in a curve of a marked increase following training to modest decay over time, stabilizing at a level significantly higher than the baseline.At stage 1, prior to the participants receiving the training, 3.7% achieved the pass mark of 80%.
The first run of 10 trials was conducted at 180 ms target duration, followed by subsequent runs of trials (different stimuli each run) at durations increasing by 50 ms each run (e.g., 180, 230, 280 ms etc)., until the participant achieved the pass score of 70% correct on trials with no eye movement.
Participants could re-take this quiz as many times as was necessary to achieve the passing grade of 70% and progress to the next unit.
Post-workshop, the mean total test score was 78/156 (range 32 to 124), with 77% achieving the pass mark.
At follow-up, the mean total score was 82/156 (range 36 to 155), with 61% achieving the pass mark (see Table 3).
Tables 2 to 4 summarise mean changes from baseline, patients achieving the MCII threshold, and patients achieving the PASS threshold for OA pain (Table 2; Figure 2a), the patient's global assessment of disease activity (Table 3; Figure 3a), and WOMAC™ Function subscale score at week 13 (Table 4; Figure 4a).
